BioVentureHub collaboration with My Green Lab

WRITTEN BY

Jamie Smith

BioVentureHub collaborates with My Green Lab to extend AstraZeneca’s sustainability approach to emerging life science companies

The BioVentureHub, an AstraZeneca health innovation hub in Sweden, is pleased to announce a collaboration with leading non-profit, environmental organisation, My Green Lab, to extend a global AstraZeneca green lab certification program to the emerging life science companies in the BioVentureHub.

A recent report1 by My Green Lab on the carbon impact of biotech and pharma found that while the largest companies by revenue have reduced carbon emissions year on year since at least 2015, the majority of companies within the biotechnology and pharmaceutical industry do not have climate commitments in line with the Paris Agreement’s goal of keeping planetary warming to 1.5˚C above pre-industrial levels.

AstraZeneca’s leadership in sustainability has been widely recognised. In October 2021, the company’s net zero targets were verified by the Science-Based Targets initiative (SBTi) and the Dow Jones Sustainability index (DJSI) recently highlighted AstraZeneca’s position as one of the most sustainable pharmaceutical companies.

Through its unique location at the heart of the AstraZeneca site in Gothenburg, the BioVentureHub is ideally positioned to inspire smaller, emerging companies to play their part to act and deliver to improve public and planetary health. Besides sharing sustainability learnings and best practices through seminars and training sessions together with AstraZeneca and My Green Lab experts, BioVentureHub companies also benefit from AstraZeneca sustainability initiatives such as 100% renewable energy, ISO 14001 certification, waste management and the SmartMover scheme to facilitate sustainable travel.

Taking this further, the BioVentureHub is now collaborating with AstraZeneca and My Green Lab to extend the AstraZeneca green lab certification program to lab companies in the BioVentureHub. Through a unique, customised program, participating companies will get help to better understand sustainable lab practices and learn new ways to reduce the environmental impact of their labs. Besides benefitting from experiences and learnings of AstraZeneca and My Green Lab, the BioVentureHub program is also being set up to help companies share with, and learn from, each other.

Twelve out of thirteen lab companies in the BioVentureHub are participating in the program which starts in December 2021 and continues during the first half of 2022.

Magnus Björsne, CEO for AstraZeneca’s BioVentureHub, says, “The BioVentureHub’s sustainability strategy builds on and amplifies AstraZeneca’s commitment to sustainability. By repurposing and sharing infrastructure, expertise and ideas, such as the My Green Lab certification program, we are supporting the sustainable growth of smaller companies and contributing to healthy businesses, healthy people and a healthy planet.”

Penny James, Chief Operating Officer, BioPharmaceuticals R&D at AstraZeneca, comments, “Labs at all of our R&D sites are now My Green Lab certified. Working with My Green Lab has provided us with a framework and expertise to continuously improve the environmental sustainability of our labs. It feels very rewarding to now be able to share good sustainability practices more widely with the BioVentureHub companies. In this way, more companies can help to accelerate improvements to environmental impact and support sustainable ecosystems for healthcare.”

Dr. Rachael Relph, Chief Sustainability Officer at My Green Lab, says, “We are proud and excited to have the opportunity to engage, certify and advise the emerging life science companies in the BioVentureHub on lab sustainability best practices. Through this collaboration, we have the opportunity to help more scientists explore ways to reduce the environmental impact of their work.”

Philip Thormark, Executive Director at UN Global Compact Network Sweden, says, “This circular collaboration is a great example of how sustainability work in a large organisation can be reused to help smaller companies on their sustainability journey − creating value for the companies involved and society at large.”

===

For more information, please contact

Pernilla Isberg

AstraZeneca BioVentureHub

+46 (0)709-670073

pernilla.isberg@astrazeneca.com

Namrata Jain

My Green Lab

+1.778.319.8194

namrata@mygreenlab.org

===

AstraZeneca’s BioVentureHub

AstraZeneca established the BioVentureHub in 2014 as an open innovation ecosystem to further strengthen competitiveness and dynamism in the life science industry. The BioVentureHub is based on an innovative public-private-partnership model and is located at the heart of AstraZeneca Gothenburg. It gives emerging life science companies and academic groups a unique opportunity to co-locate with and tap into the power of AstraZeneca’s world-class scientists and state of the art lab facilities and infrastructure, and with each other. Please visit www.azbioventurehub.com and follow us on LinkedIn @BioVentureHub.

My Green Lab®

My Green Lab is a non-profit environmental organization with a mission to build a global culture of sustainability in science. The organization is the world leader in developing internationally recognized sustainability standards for laboratories and laboratory products—bringing sustainability to the community responsible for the world's life-changing medical and technical innovations. Laboratories are some of the most resource-intensive spaces in any industry, but they don't have to be. By introducing a new perspective and proven best practices within a carefully crafted framework, My Green Lab has inspired tens of thousands of scientists and lab professionals to make positive changes in their labs by reducing the environmental impact of their work. Please visit us on www.mygreenlab.org and follow us on LinkedIn @My Green Lab.

AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.

UN Global Compact Network Sweden

UN Global Compact Network Sweden (GCNS) is Sweden’s largest collaboration in corporate sustainability with more than 450 members. The network was founded in 2018 as the Swedish national network for the UN Global Compact and is today the natural meeting place to receive support and exchange experiences around strategic sustainability work. GCNS works on the basis of the UN Global Compact’s Ten Principles and the Global Goals to support Swedish companies and organizations to accelerate their sustainability efforts and contribute to a better world. Please visit www.globalcompact.se and follow us on LinkedIn @UN Global Compact Network Sweden

===

References

1 The Carbon Impact of Biotech & Pharma A ROADMAP TO 1.5°C. Produced by My Green Lab in collaboration with Urgentem. October 2021

My Green Lab Certification program

Sustainability at AstraZeneca

The BioVentureHub and sustainability

 

Photo: Catharina Fyrberg